Research Article

Novel Value of Preoperative Gamma-Glutamyltransferase Levels in the Prognosis of AFP-Negative Hepatocellular Carcinoma

Table 1

Clinical characteristics of patients.

Variables () and () () value

Age (years)0.060
Sex<0.001
 Male181 (85.8)305 (95.3)142 (96.6)
 Female30 (14.2)15 (4.7)5 (3.4)
Cause of disease0.702
 HBV179 (84.8)278 (86.9)126 (85.7)
 HCV2 (0.9)7 (2.2)4 (2.7)
 Others31 (14.7)40 (12.5)19 (12.9)
Platelet count (109/L)0.448
Liver cirrhosis0.167
 Present112 (53.1)195 (60.9)89 (60.5)
 Absent99 (46.9)125 (39.1)58 (39.5)
Albumin (g/L)0.051
Serum total bilirubin (μmol/L)0.424
ALBI grade
 1183 (86.7)254 (79.4)115 (78.2)0.055
 228 (13.3)66 (20.6)32 (21.8)
Tumor size (cm)<0.001
Tumor number0.009
 ≤1190 (90.0)263 (82.2)116 (78.9)
 >121 (10.0)57 (17.8)31 (21.1)
Tumor extent0.119
 Unilobar206 (97.6)303 (94.7)137 (93.2)
 Bilobar5 (2.4)17 (5.3)10 (6.8)
Microvascular invasion0.001
 Absent189 (89.6)268 (83.8)109 (74.1)
 Present22 (10.4)52 (16.2)38 (25.9)
Surgical time (min)0.065
Type of hepatectomy0.107
 Major36 (17.1)61 (19.1)38 (25.9)
 Minor175 (82.9)259 (80.9)109 (74.1)
Surgical margin (cm)0.062
 <173 (34.6)136 (42.5)68 (46.3)
 ≥1138 (65.4)184 (57.5)79 (53.7)
Intraoperative blood loss (mL)<0.001
 <400160 (75.8)217 (67.8)71 (48.3)
 ≥40051 (24.2)103 (32.2)76 (51.7)
Encapsulation0.414
 Complete104 (49.3)149 (46.6)62 (42.2)
 Incomplete107 (50.7)171 (53.4)85 (57.8)
Tumor differentiation0.235
 Well48 (22.7)57 (17.8)24 (16.3)
 Moderate or poor163 (77.3)263 (82.2)123 (83.7)
BCLC stage<0.001
 A200 (94.8)288 (90.0)121 (82.3)
 B10 (4.7)27 (8.4)8 (5.4)
 C1 (0.5)5 (1.6)18 (12.3)

Variables are expressed as no. (%). HBV: hepatitis B virus; HCV: hepatitis C virus; ALBI grade: albumin-bilirubin grade; BCLC: Barcelona Clinic Liver Cancer. Major liver resection: resection with more than two lobes; minor liver resection: resection with no more than two lobes. Surgical margin: the shortest measured distance from the edge of the tumor to the plane of liver transection.